Reduced Progression of Cardiac Allograft Vasculopathy with Routine Use of Induction Therapy with Basiliximab

BACKGROUND: Cardiac allograft vasculopathy (CAV) is a major limitation for long-term survival of patients undergoing heart transplantation (HT). Some immunosuppressants can reduce the risk of CAV. OBJECTIVES: The primary objective was to evaluate the variation in the volumetric growth of the intimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ricardo, Moura, Lidia Ana Zytynski, Lopes, Sergio Veiga, da Costa, Francisco Diniz Affonso, Souza Filho, Newton Fernando Stadler, Fernandes, Tiago Luiz, Salvatti, Natália Boing, Faria Neto, José Rocha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559127/
https://www.ncbi.nlm.nih.gov/pubmed/26107815
http://dx.doi.org/10.5935/abc.20150063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559127/
https://www.ncbi.nlm.nih.gov/pubmed/26107815
http://dx.doi.org/10.5935/abc.20150063

Ejemplares similares